PLP1 and Spastic paraplegia type 2: In humans, mutations in the PLP1 gene including null, point and duplication/triplication changes, cause allelic leukodystrophies with a broad range of clinical severity, from spastic paraplegia type 2 (SPG2) to the connatal forms of PMD.